David M. Devilbiss

Cerora, Inc. provides neuro diagnostic information technology solutions. Its applications include concussion/mTBI management, neurodegeneration/Alzheimer’s management and non-medical uses. The firm's product Cerora Borealis is a medical device platform to measure and record brainwave activity as well as other biosensor data, including cognitive data and voice-based data streams. Its platform provides state of the art, mobile and versatile multimodal biosensor data. The company was founded by Adam J. Simon and David M. Devilbiss in 2011 and is headquartered in Bethlehem, PA.